HUB Organoids predict patient response to treatment.
Our technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
What can we do for you?
Drug development
Reduce drug attrition and predict patient response with our preclinical services and clinical trials in a dish
Custom solutions
Decipher the complexity of the human disease with our custom model and assay development services
Access our biobank
1000s of established models – from both normal and diseased tissue
Licensing program
Bring HUB Organoid Technology and knowhow in-house
We’re already making an impact
by bringing next-generation therapeutics to patients
Bring HUB Organoid Technology and knowhow in-house
Outsource your drug development program
Latest news
NEWS AND INSIGHTS
First clinical candidate developed using HUB Organoids makes it to clinical trials within five years